| Pharmaceutical active ingredients: |
| Erlotinib |
| Available forms, composition and doses of Tarceva: |
| Tablets, Film-Coated; Oral; Erlotinib Hydrochloride 100 mgTablets, Film-Coated; Oral; Erlotinib Hydrochloride 150 mgTablets, Film-Coated; Oral; Erlotinib Hydrochloride 25 mgTablets, Film-Coated; Oral; Erlotinib Hydrochloride 50 mgTablets; Oral; Erlotinib Hydrochloride 100 mgTablets; Oral; Erlotinib Hydrochloride 150 mgTablets; Oral; Erlotinib Hydrochloride 25 mg |
| Tarceva medical category: |
| Human:Antineoplastic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XE03 - Erlotinib |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheDKSHFirma Chun CheongGenentechOSI PharmaceuticalsSchwarz PharmaZuellig Pharma |
| Related documents and information about Tarceva: |
| Tarceva prescribing information (PDF) |